Researchers found that men with genetically higher tyrosine levels appeared to live slightly shorter lives, raising new ...

Q1 2026 Management view Dr. Frank Bedu-Addo (President, CEO & Director) said the quarter’s “major focus was on advancing our clinical programs,” and handed the program update to the CMO, pointing to ...

In patients admitted to the hospital with worsening HF, an early discharge strategy involving treatment at home with ...

In a rare unanimous decision last month, the Pennsylvania Supreme Court ruled that the public should have access to ...

The court ordered counties to release granular data on individual ballots, but some are unsure if they can comply and still ...

Obesity and higher visceral adipose tissue (VAT) levels are associated with greater BMD and a lower risk for osteoporosis.

What is MR: MR uses genetic variants as tools to infer causality between exposures and outcomes, reducing confounding common in observational studies. Why it matters: It offers a way to test causal ...

D-150 4FRONT-1 wet AMD Phase 3 randomization complete (N=523); topline data expected in H1 20274FRONT-2 enrollment completion expected in H2 ...

Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028. Strasbourg, France, April 13, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company ...

A successful clinical trial requires an effective randomization strategy formulated by innovative thinking to meet unique demands. In a recent webinar, Solventum revealed how the eClinical platform ...